Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal...

Area of Science:

• Neuroscience
• Neuropharmacology
• Ischemic Stroke Research

Background:

• Hypoxia and hypoglycemia (ischemia) can cause significant neuronal damage in the brain.
• Vasopressin-related neuropeptides play various roles in the central nervous system, but their specific involvement in ischemic neuronal deficits is not fully understood.

Purpose of the Study:

• To investigate the role of vasopressin-related neuropeptides in ischemia-induced neuronal damage in the rat hippocampus.
• To determine the specific vasopressin receptor subtypes involved in mediating these effects.

Main Methods:

• Electrophysiological recordings of CA1 presynaptic potentials in rat hippocampal slices subjected to oxygen-glucose deprivation (ischemia).
• Application of arginine-vasopressin (AVP), a V1 receptor antagonist, a V2 receptor antagonist, and the AVP metabolite AVP4-9.
• Assessment of the neuroprotective or detrimental effects of these agents on ischemic neuronal damage.

Main Results:

• Arginine-vasopressin (AVP) treatment potentiated the decrease in CA1 presynaptic potential during ischemia.
• A V1 receptor antagonist demonstrated a dose-dependent neuroprotective effect, completely blocking the AVP-induced deficit.
• A V2 receptor antagonist had no significant effect.
• The AVP metabolite AVP4-9 exacerbated the ischemic decrease more than AVP itself.

Conclusions:

• V1 receptor stimulation exacerbates, while V1 receptor blockade confers neuroprotection against, ischemic neuronal damage in the hippocampus.
• AVP may contribute to ischemic neuronal deficits through V1 receptor activation.
• Targeting V1 receptors could be a potential therapeutic strategy for stroke.